Beyer A-M, Rosche B, Pleyer U, Wandinger K P
Neurologische Klinik und Poliklinik, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, Berlin, Germany.
Nervenarzt. 2007 Dec;78(12):1389-98. doi: 10.1007/s00115-007-2297-x.
An involvement of the visual system can be found in many neurologic diseases. Especially demyelinating processes of the central nervous system (CNS) and multiple sclerosis (MS) in particular present with a variety of ophthalmological abnormalities. While optic neuritis (ON) is known to be a positive predictor for the development of MS and can be considered a symptom of the disease, the high frequency of uveitis observed in MS patients seems to occur rather in the context of a general predisposition for autoimmune disorders. However, MS-associated uveitis can precede the onset of neurological symptoms by many years and shows response to treatment with steroids and interferons, suggesting the presence of similar underlying pathogenic mechanisms. Therefore, further studies are warranted in order to reveal whether administration of early immunomodulatory therapy can delay or even prevent the clinical manifestation of MS in a distinct subgroup of patients presenting with uveitis.
视觉系统受累可见于多种神经系统疾病。尤其是中枢神经系统(CNS)的脱髓鞘过程,特别是多发性硬化症(MS),会出现多种眼科异常。虽然视神经炎(ON)是MS发病的一个阳性预测指标,可被视为该疾病的一种症状,但在MS患者中观察到的葡萄膜炎高发似乎更多是在自身免疫性疾病的一般易感性背景下发生的。然而,与MS相关的葡萄膜炎可在神经症状出现前数年发生,并对类固醇和干扰素治疗有反应,这表明存在相似的潜在致病机制。因此,有必要进一步研究,以揭示早期免疫调节治疗的给药是否能延缓甚至预防在出现葡萄膜炎的特定亚组患者中MS的临床表现。